Toggle light / dark theme

Google shows off Lumiere, a space-time diffusion model for realistic AI videos

Lumiere, on its part, addresses this gap by using a Space-Time U-Net architecture that generates the entire temporal duration of the video at once, through a single pass in the model, leading to more realistic and coherent motion.

“By deploying both spatial and (importantly) temporal down-and up-sampling and leveraging a pre-trained text-to-image diffusion model, our model learns to directly generate a full-frame-rate, low-resolution video by processing it in multiple space-time scales,” the researchers noted in the paper.

The video model was trained on a dataset of 30 million videos, along with their text captions, and is capable of generating 80 frames at 16 fps. The source of this data, however, remains unclear at this stage.

Forever working: Gadget plans to tap into your productivity while you sleep by inducing lucid dreaming

ICYMI: INTRODUCING MORPHEUS-1 The world’s first multi-modal generative ultrasonic transformer designed to induce and stabilize lucid dreams according to Porphetic #AI Available for beta users Spring 2024.


Startup company Prophetic is set to unveil the “Halo” device to induce lucid dreaming, Fortune reports.

Italian team’s iCub3 avatar tech set to enhance human-robot connection

Advanced proposition

The iCub3 robot avatar system has been designed to facilitate the embodiment of humanoid robots by human operators, encompassing aspects such as locomotion, manipulation, voice, and facial expressions with comprehensive sensory feedback, including visual, auditory, haptic, weight, and touch modalities.

The iCub3 avatar system consists primarily of the iCub3 humanoid robot, an evolved version of the IIT’s humanoid robot born two decades ago, and innovative wearable technologies named iFeel.

Facebook Researchers Test AI’s Intelligence and Find It Is Unfortunately Quite Stupid

A team of researchers at Facebook’s parent company Meta has come up with a new benchmark to gauge the abilities of AI assistants like OpenAI’s large language model GPT-4.

And judging by current standards, OpenAI’s current crop of AI models are all… still pretty stupid.

The team, which includes “AI godfather” and Meta chief scientist Yann LeCun, came up with an exam called GAIA that’s made up of 466 questions that “are conceptually simple for humans yet challenging for most advanced AIs,” per a yet-to-be-peer-reviewed paper.

Analyzing microscopic images: New open-source software makes AI models lighter, greener

Artificial intelligence (AI) has become an indispensable component in the analysis of microscopic data. However, while AI models are becoming better and more complex, the computing power and associated energy consumption are also increasing.

Researchers at the Leibniz-Institut für Analytische Wissenschaften (ISAS) and Peking University have therefore created a free compression software that allows scientists to run existing bioimaging AI models faster and with significantly lower .

The researchers have presented their user-friendly toolbox, called EfficientBioAI, in an article published in Nature Methods.

Researchers develop machine-learning tool to detect cancer earlier via liquid biopsy

Researchers at City of Hope and Translational Genomics Research Institute (TGen) have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws. The study is published in the journal Science Translational Medicine.

“A huge body of evidence shows that caught at later stages kills people. This new technology gets us closer to a world where people will receive a annually to detect cancer earlier when it is more treatable and possibly curable,” said Cristian Tomasetti, Ph.D., corresponding author of the new study and director of City of Hope’s Center for Cancer Prevention and Early Detection.

Tomasetti explained that 99% of people diagnosed with Stage 1 will be alive five years later; however, if it is found at Stage 4, when disease has spread to other organs, the five-year survival drops to 31%.